UNSPSC 51372317: Norpipanone

This classification denotes an analgesic agent with the molecular formula C23H29NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 127X8DJ74M, chemically known as 4,4-diphenyl-6-piperidino-3-hexanon but generally known as norpipanone, which bears US NIH Compound Identifier 22391. European Medicines Agency schedules Norpipanone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09378MIG. The term NORPIPANONE is an International Non-Proprietary Name.

UNSPSC 51372317 Norpipanone is a Commodity code that does not map clearly to the state and local opportunities recently posted under it. The three most recent solicitations—from Seminole County, Florida; Texas Health and Human Services Commission; and the Minnesota Multistate Cooperative Purchasing Alliance—concern naloxone procurement, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products respectively. None of these align with norpipanone, a synthetic opioid pharmaceutical intermediate with limited legitimate clinical use. The code shows little relevant recent activity in state and local government procurement.

The mismatch between the code's nominal scope and the actual solicitations suggests either a classification error in the posting systems or that the code has been applied inconsistently across jurisdictions. State and local procurement professionals evaluating norpipanone as a commodity line should verify the correct UNSPSC classification through their procurement office or source-system administrator before pursuing opportunities tagged to 51372317.